COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel
Study Identifier
P16-831
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
The purpose of this study is to evaluate treatment of advanced Parkinson's Disease (PD) patients on levodopa-carbidopa intestinal gel (LCIG) monotherapy in a routine clinical setting.
Study Locations
Location
Status
Location
Gailtal Klinik /ID# 202505
Hermagor-Pressegger See, Carinthia, Austria, 9620
Status
Not applicable
Location
Medizinische Universität Graz /ID# 202559
Graz, Styria, Austria, 8010
Status
Not applicable
Location
University of Calgary /ID# 206550
Calgary, Alberta, Canada, T2N 4Z6
Status
Not applicable
Location
Ottawa Hospital /ID# 169448
Ottawa, Ontario, Canada, K1Y 4E9
Status
Not applicable
Location
Toronto Western Hospital /ID# 169038
Toronto, Ontario, Canada, M5T 2S8
Status
Not applicable
Location
Clinique Neuro Levis /ID# 206549
Lévis, Quebec, Canada, G6W 0M5
Status
Not applicable
Showing {first} - {last} of {total} Results